Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Dupilumab is also approved by EMA for severe refractory asthma in patients aged at least 6 years, for adults patients affected by CRSwNP, and for EoE in adults and children over 1 year of age ...

Asthma is a chronic inflammatory disease of the airways characterized ... and their respective receptors. Compared to dupilumab, which targets only IL-4Rα and has limited efficacy in severe disease, ...

Dupixent (dupilumab) is a brand-name injection that’s prescribed for treating asthma. This article covers topics such as side effects, dosage, and how Dupixent works. Dupixent is available as a ...

Asthma is a serious medical condition that causes inflammation and constriction of the airways. If left untreated, it can affect your quality of life. A severe asthma attack can sometimes be fatal.

The Bonn researchers found that comorbidities with a chronic inflammatory disease—in particular atopic dermatitis, bronchial asthma, Hashimoto's thyroiditis, rhinitis or vitiligo—were ...